RISA Labs develops BOSS Console, an AI-driven operating system that plugs into cancer centers’ EMRs, payer portals and other systems to automate patient access, benefits verification, and prior authorization. Its agent-based software reads, reasons and acts across disparate data sources, adapting in real time to changing payer rules and clinical requirements. Deployed at leading U.S. oncology networks, the platform has freed roughly 80 % of administrative staff time, cut denials by up to 40 %, achieved 97.8 % first-pass approval rates, and reduced authorization turnaround from an 8-day backlog to under 24 hours (with a goal of <2 hours). More than 20 full-time equivalents at one site have been redeployed to higher-value tasks, improving both capacity and financial performance. The company’s immediate roadmap includes expanding AI-driven workflows across the full continuum of cancer care and extending its technology to specialty pharmacy operations. Financially, RISA Labs has secured $11.1 million in Series A funding to accelerate nationwide deployment. Founded by CEO Kshitij Jaggi and CTO Kumar Shivang, the company operates out of Palo Alto, California.

Total raised

$15M

Funding rounds

2

Latest round

Series A

Latest activity

Jan 2026